CPT® Code 90723

Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use

The CPT® Code 90723 refers to a combination vaccine that includes diphtheria, tetanus toxoids, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine, specifically formulated for intramuscular administration. This vaccine is designed to provide comprehensive protection against several serious infectious diseases. Diphtheria and tetanus are caused by bacterial toxins, and the toxoids in the vaccine stimulate the immune system to produce antibodies that neutralize these toxins, thereby offering long-lasting immunity. The acellular pertussis component is a more refined version of the pertussis vaccine, which is designed to minimize side effects while still effectively stimulating the immune response. The hepatitis B component protects against the hepatitis B virus, which can lead to chronic liver disease, and the inactivated poliovirus vaccine helps prevent poliomyelitis, a viral disease that can cause paralysis. The combination of these vaccines into a single injection simplifies the immunization process, ensuring that patients receive essential vaccinations in a more efficient manner. Code 90723 specifically denotes the administration of this combination vaccine, focusing on the product used rather than the individual components or the clinical indications for vaccination.